BridgeBio Pharma has taken another…
BridgeBio Pharma has taken another step toward the potential approval [...]
Evotec has escalated its already…
Evotec has escalated its already substantial reorganization, plotting an additional [...]
As AstraZeneca kicks off the third…
As AstraZeneca kicks off the third year of its hockey-themed [...]
Eli Lilly continued staggering…
Eli Lilly continued staggering sales growth in the fourth quarter, [...]
Veeva Systems, which offers life…
Veeva Systems, which offers life sciences companies cloud-based commercial management [...]
With a fresh leadership team…
With a fresh leadership team settling in, CNS Pharmaceuticals is [...]
Salspera has set out plans for a…
Salspera has set out plans for a $91 million IPO [...]
Sandoz is committing even further…
Sandoz is committing even further to its biosimilar business with [...]
In his second year as CEO,…
In his second year as CEO, AbbVie’s Robert Michael received [...]
Less than a week after Roche…
Less than a week after Roche pledged a hefty investment [...]